Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry

Osteoporosis International

Volumn 16, Issue 7, 2005, Pages 764-772

  Rud, B ^a   Jensen, J E B ^a   Mosekilde, L ^b   Nielsen, S P ^c   Hilden, J ^d   Abrahamsen, B ^e  

^a HVIDOVRE HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c HILLERØD HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Decision support techniques; Densitometry X ray; Mass screening; Osteoporosis, postmenopausal; Practice guidelines; Sensitivity and specificity

Indexed keywords

ADULT; ARTICLE; BONE DENSITOMETRY; CLIMACTERIUM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DUAL ENERGY X RAY ABSORPTIOMETRY; EARLY DIAGNOSIS; FEMALE; FEMUR NECK; HIP; HUMAN; INTERMETHOD COMPARISON; LUMBAR SPINE; MEDICAL DECISION MAKING; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR; ROC CURVE; SAMPLE SIZE; SCORING SYSTEM; SCREENING TEST;

ADULT; AREA UNDER CURVE; DECISION MAKING; DENSITOMETRY, X-RAY; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT SELECTION; QUESTIONNAIRES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 21644453637     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-004-1748-5     Document Type: Article

References (46)

1. Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J et al. (1999) Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10:259-264
2. Kanis J, Delmas PD, Burckhardt P, Cooper C, Torgerson D (1997) Guidelines for the prevention and management of osteoporosis. Osteoporos Int 7:390-406
3. Meunier PJ, Delmas PD, Eastell R, McClung MR, Papapoulos S, Rizzoli R et al. (1999) Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther 21:1025-1044
4. Espallargues M, Sampietro-Colom L, Estrada MD, Sola M, del Rio L, Setoain J et al. (2001) Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int 12:811-822
5. Hodson J, Marsh J (2003) Quantitative ultrasound and risk factor enquiry as predictors of postmenopausal osteoporosis: comparative study in primary care. BMJ 326:1250-1251
6. Versluis RG, Papapoulos SE, de Bock GH, Zwinderman AH, Petri H, van de Ven CM et al. (2001) Clinical risk factors as predictors of postmenopausal osteoporosis in general practice. Br J Gen Pract 51:806-810
7. Lydick E, Cook K, Turpin J, Melton M, Stine R, Byrnes C (1998) Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manag Care 4:37-48
8. Cadarette SM, Jaglal SB, Kreiger N, McIsaac WJ, Darlington GA, Tu JV (2000) Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ 162:1289-1294
9. Koh LK, Sedrine WB, Torralba TP, Kung A, Fujiwara S, Chan SP et al. (2001) A simple tool to identify asian women at increased risk of osteoporosis. Osteoporos Int 12:699-705
10. Laupacis A, Sekar N, Stiell IG (1997) Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 277:488-494
11. Ben Sedrine W, Devogelaer JP, Kaufman JM, Goemaere S, Depresseux G, Zegels B et al. (2001) Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in a sample of white women from Belgium. Bone 29:374-380
12. Cadarette SM, Jaglal SB, Murray TM (1999) Validation of the simple calculated osteoporosis risk estimation (SCORE) for patient selection for bone densitometry. Osteoporos Int 10:85-90
13. Cadarette SM, Jaglal SB, Murray TM, McIsaac WJ, Joseph L, Brown JP (2001) Evaluation of decision rules for referring women for bone densitometry by dual-energy X-ray absorptiometry. JAMA 286:57-63
14. Geusens P, Hochberg MC, van der Voort DJ, Pols H, van der Klift M, Siris E et al. (2002) Performance of risk indices for identifying low bone density in postmenopausal women. Mayo Clin Proc 77:629-637
15. Russell AS, Morrison RT (2001) An assessment of the new "SCORE" index as a predictor of osteoporosis in women. Scand J Rheumatol 30:35-39
16. Ungar WJ, Josse R, Lee S, Ryan N, Adachi R, Hanley D et al. (2000) The Canadian SCORE questionnaire: optimizing the use of technology for low bone density assessment. Simple Calculated Osteoporosis Risk Estimate. J Clin Densitom 3:269-280
17. Von Muhlen D, Visby LA, Barrett-Connor E, Bettencourt R (1999) Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in older Caucasian women: the Rancho Bernardo study. Osteoporos Int 10:79-84
18. Del Mar C, Glasziou P (2003) How many conditions can a GP screen for? BMJ 327:1117
19. Mosekilde L, Hermann AP, Beck-Nielsen H, Charles P, Nielsen SP, Sorensen OH (1999) The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2000 normal perimenopausal women. Maturitas 31:207-219
20. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
21. Abrahamsen B, Gram J, Hansen TB, Beck-Nielsen H (1995) Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements. Bone 16:385-390
22. Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP et al. (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468-489
23. Sedrine WB, Reginster JY (2003) Using the OST index to identify women at risk of osteoporosis: a validation study in Belgium. Osteoporos Int 13:S109
24. Armitage P., Berry G. (1987) Statistical inference. Statistical methods in medical research, 3rd edn. Blackwell, Oxford, pp 93-140
25. Report of a WHO study group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO, Geneva
26. Pouilles JM, Tremollieres F, Ribot C (1993) Spine and femur densitometry at the menopause: are both sites necessary in the assessment of the risk of osteoporosis? Calcif Tissue Int 52:344-347
27. Hamdy RC, Petak SM, Lenchik L (2002) Which central dual X-ray absorptiometry skeletal sites and regions of interest should be used to determine the diagnosis of osteoporosis? J Clin Densitom 5:S11-S18
28. Wildner M, Peters A, Raghuvanshi VS, Hohnloser J, Siebert U (2003) Superiority of age and weight as variables in predicting osteoporosis in postmenopausal white women. Osteoporos Int 14:950-956
29. Dargent-Molina P, Poitiers F, Breart G (2000) In elderly women weight is the best predictor of a very low bone mineral density: evidence from the EPIDOS study. Osteoporos Int 11:881-888
30. Vestergaard P, Hermann AP, Gram J, Jensen LB, Eiken P, Abrahamsen B et al. (2001) Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women. Maturitas 40:211-220
31. US Preventive Services Task Force (2002) Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Int Med 137:526-528
32. Schuit SC, van der KM, Weel AE, de Laet CE, Burger H, Seeman E, Hofman A, Uitterlinden AG, van Leeuwen JP, Pols HA (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 34:195-202
33. Law MR, Wald NJ, Meade TW (1991) Strategies for prevention of osteoporosis and hip fracture. BMJ 303:453-459
34. Mosekilde L, Beck-Nielsen H, Sorensen OH, Nielsen SP, Charles P, Vestergaard P et al. (2000) Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study. Maturitas 36:181-193
35. Koster A (1990) Hormone replacement therapy: use patterns in 51-year-old Danish women. Maturitas 12:345-356
36. Oddens BJ, Boulet MJ (1997) Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance. Obstet Gynecol 90:269-277
37. Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427
38. Grady D (2003) Postmenopausal hormones-therapy for symptoms only. N Engl J Med 348:1835-1837
39. McPherson K (2004) Where are we now with hormone replacement therapy? BMJ 328:357-358
40. Lagro-Janssen T, Rosser WW, van Weel C (2003) Breast cancer and hormone-replacement therapy: up to general practice to pick up the pieces. Lancet 362:414-415
41. Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929-1936
42. Liberman UA, Weiss SR, Broil J, Minne HW, Quan H, Bell NH et al. (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437-1443
43. Heaney RP, Zizic TM, Fogelman I, Olszynski WP, Geusens P, Kasibhatla C et al. (2002) Risedronate reduces the risk of first vertebral fracture in osteoporotic women. Osteoporos Int 13:501-505
44. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK et al. (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637-645
45. Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA et al. (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280:2077-2082
46. Bossuyt PM, Lijmer JG, Mol BW (2000) Randomised comparisons of medical tests: sometimes invalid, not always efficient. Lancet 356:1844-1847